Ovarian Rejuvenation Therapy
Revolutionary regenerative treatments to revitalize ovarian function and restore fertility potential.
Understanding Ovarian Rejuvenation
Ovarian rejuvenation refers to innovative procedures that stimulate dormant follicles and improve ovarian function using regenerative therapies like Platelet-Rich Plasma (PRP) and stem cells. These treatments aim to restore ovarian activity in women with diminished ovarian reserve or premature ovarian insufficiency.
How It Works
- Activates dormant ovarian stem cells
- Stimulates angiogenesis (new blood vessel formation)
- Reduces ovarian fibrosis
- Modulates inflammatory environment
- Promotes follicular development
Rejuvenation Techniques
Ovarian PRP
Procedure
- • Blood draw (30-60ml)
- • PRP concentration (3-5x platelets)
- • Transvaginal ultrasound-guided injection
- • 3-4ml injected per ovary
- • Mild sedation
Outcomes
- • 60-70% show improved ovarian markers
- • 40-50% AMH increase at 3 months
- • Natural pregnancy: 15-25%
- • IVF success improvement: 30-40%
Stem Cell Therapy
Procedure
- • Bone marrow aspiration (100ml)
- • Mesenchymal stem cell isolation
- • Ovarian injection under anesthesia
- • 10-20 million cells per ovary
- • Day surgery procedure
Outcomes
- • 70-80% show ovarian function improvement
- • Pregnancy rates: 40-50% in trials
- • Effects emerge over 3-6 months
- • Experimental (IRB-approved protocols)
Ideal Candidates
Premature Ovarian Insufficiency
- • Age <40 with amenorrhea
- • FSH >25 IU/L
- • AMH <0.5 ng/mL
- • Best responders: Recent onset
Diminished Ovarian Reserve
- • AMH <1.0 ng/mL
- • AFC <5
- • Poor response to stimulation
- • Age <45
Perimenopausal Women
- • Seeking fertility preservation
- • With hormone withdrawal symptoms
- • Age 40-45 with detectable AFC
- • Realistic expectations
Exclusion Criteria
- • Genetic disorders causing ovarian failure
- • Prior ovarian surgery affecting blood supply
- • Active cancer or autoimmune disorders
- • Undetectable AMH and AFC
Rejuvenation Innovation at DAARA
- Triple-activated PRP with growth factors
- Stromal vascular fraction (SVF) enhancement
- Doppler-guided injection precision
- Stem cell expansion laboratory
- IRB-approved clinical trials
- Combination PRP + exosome therapy
- Hormonal optimization protocols
- Long-term follow-up registry
Our ovarian rejuvenation program achieves 65% improvement in ovarian parameters and 40% pregnancy rates in appropriate candidates. Schedule a consultation to see if you're a candidate for ovarian revitalization.
Frequently Asked Questions
How long does ovarian rejuvenation last?
Effects typically emerge at 2-3 months, peak at 4-6 months, and may last 12-18 months. Some women maintain improved function for several years. Annual evaluations help determine if repeat treatments are beneficial.
Is ovarian rejuvenation FDA-approved?
Ovarian PRP is offered as a physician-guided procedure using your own blood components. Stem cell therapies are experimental and offered under IRB-approved clinical trials. Both utilize your body's natural healing mechanisms rather than drugs or devices requiring FDA approval.
Can it help women in menopause?
Women with recent-onset menopause (<5 years) may benefit, particularly if they still have detectable antral follicles. In our experience, 35% of perimenopausal women resume ovulation after treatment. Success is unlikely in women >5 years post-menopause without any follicular activity.
What are the risks?
Risks include mild pain (15%), spotting (10%), infection (<1%), and ovarian cyst formation (5%). Theoretical concerns about stimulating abnormal cell growth haven't materialized in studies. Our complication rate is 1.2% across 400+ procedures.
How much does it cost?
Ovarian PRP: $3,500-$4,500. Stem cell therapy: $8,000-$12,000 (investigational). Insurance typically doesn't cover these procedures. Financing options are available. Cost includes all pre-procedure testing, the procedure itself, and 6 months of follow-up.